Gary

MicroRNAs (miRNAs) are like the secret agents of the cell. These tiny 22-nucleotide RNA molecules don’t produce proteins or engage in any flashy activities—they simply manage who gets to do what behind the scenes. In 2024, Gary Ruvkun finally received the recognition he deserved, winning the Nobel Prize for his contributions to understanding these little genetic overseers. About time, right?  

So, what exactly do miRNAs do? They thrive on drama. Take telomerase, for instance—this enzyme is crucial for maintaining your telomeres (the protective DNA caps at the ends of your chromosomes). Telomeres are like the plastic tips on shoelaces: when they wear down, it’s game over for your cells. They protect important genetic information. MicroRNAs can choose to either support telomerase in keeping cells youthful or allow those caps to deteriorate. Sounds great, except sometimes they get too generous—like when they enable cancer cells to use telomerase to achieve immortality. Thanks a lot, miRNAs.  

In tumors, miRNAs can play the role of either heroes or villains. They can deactivate cancer-causing genes (good) or mute the body’s natural defenses (very bad). This duality is why they’re central to so much cancer research—and why Ruvkun’s work was worthy of the Nobel Prize.  

Tiny molecules. Massive impact. And, apparently, a whole lot of drama.